AxioMed Spine pulls in $5M of the previously announced $15M Series D round

AxioMed® Spine Corporation Closes its Series D Financing (press release)
AxioMed® Spine Corporation (www.axiomed.com), a spinal orthopedics company focused on the development of products designed to restore spinal function in patients with degenerative spine disease by advancing the standard of care beyond fusion and first generation disc replacement, announced today that it has completed the final closing of its Series D financing, raising $5 million in two tranches from current and new investors. This funding augments the previously announced $15 million Series D financing.
AxioMed’s Freedom...